interventional-pulmonology
(4)
The Robot That Checks Its Map Mid-Flight
Noah Medical built a lung-biopsy robot around an awkward truth: the lung in the operating room may have moved since its CT scan. Galaxy updates the target while the doctor works, turning navigation into a question that can be checked.
The Company That Wants Electricity to Leave Something Behind
Galvanize built a medical device company around a curious idea: electrical pulses might kill targeted cells while leaving more of the surrounding structure intact. Its real test is now unfolding in procedure rooms and clinical studies.
CSA Medical, Inc.
CSA Medical is a Lexington, Massachusetts medical device company that develops spray cryotherapy technology for the lungs. Its flagship RejuvenAir System delivers a metered dose of -196°C liquid nitrogen through a bronchoscope to destroy the damaged, mucus-producing cells that drive chronic bronchitis in COPD patients, while preserving the underlying tissue matrix so healthy airway cells can regrow. Backed by roughly $161M in total funding including a $53M Series D in 2024, the company submitted its FDA PMA in January 2026 following a successful pivotal SPRAY-CB trial.
Interscope, Inc.
Interscope, Inc. is a Northbridge, Massachusetts medical device company that develops the EndoRotor, a flexible, powered endoscopic resection system that dissects, resects, and collects tissue in the gastrointestinal tract without thermal energy. Founded in 2011, the company created the first flexible microdebrider designed for the digestive tract and holds the first and only FDA marketing authorization for Direct Endoscopic Necrosectomy (DEN) in walled-off pancreatic necrosis. Interscope sells to interventional gastroenterologists and hospitals, and distributes the EndoRotor system through a partnership with Micro-Tech Endoscopy.